to facilitate payment and/or its posting Investigation of all rejected/return payments, open items available on BS accounts; Ad... service quality: Work according to priorities and deadlines outlined by the Manager and in line with SLAs; Maintain...
Collections Manager is critical to WBD Finance and Accounting Organization. This role plays a key part in ensuring the Company... Collections Manager will manage a team to execute on all aspects of monthly collection targets by using a combination of coaching...
Chcesz rozwijać swoją karierę w firmie, która jest liderem rynku reklamy zewnętrznej i digitalowej w Polsce? Wiemy, jak skuteczne komunikować się z klientami. Priorytetem Cityboard Media jest dostarczanie innowacyjnych rozwiązań marketing...
Cześć! 🖐 Kultura (nie tylko organizacyjna!) wymaga, żeby na dzień dobry się przedstawić. A zatem - Cityboard Media kłania się niziutko 😀 Miło mi Cię poznać! Jestem firmą ze ścisłego topu polskiego marketingu, która wyrosła z rynku rekla...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »